Table 3.
Phenotypes of osteoclastic lineage cells with modified STAT3 signaling pathway
Origin | Signaling pathway | Regulating factors | Effect on STAT3 (phosphorylation sites) | Downstream target gene | Phenotypes | Reference |
---|---|---|---|---|---|---|
RAW264.7cells and mice BMMs | STAT3/ RANKL | MSM | Decreased STAT3 phosphorylation at Ser727 | NFATc1, TRAP, OSCAR, MMP9 | Decreased cell viability and TRAP-positive multinucleated cells | [81] |
RAW264.7cells and mice BMMs | STAT3, CD9/gp130/STAT3 | WKYMVm | Decreased STAT3 phosphorylation at Ser727 | NFATc1, c-Fos, MMP9, CTSK | Decreased TRAP-positive multinucleated cells | [82] |
ST2 cells and mice BMMs | STAT3 | HA | Decreased STAT3 phosphorylation | RANKL | Decreased TRAP-positive multinucleated cells | [97] |
RAW264.7cells and mice BMMs | IL-34/STAT3/SMAD7 | IL-34 | Increased STAT3 phosphorylation | SMAD7 | Increased TRAP-positive multinucleated cells | [86] |
Mice bone marrow cells | STAT3 | Heparin | Increased STAT3-DNA binding and transactivation at Ser727 | gp130, RANKL | Increased TRAP-positive multinucleated cells | [93] |
RAW264.7cells and BMMs | STAT3 | PIAS3 | Decreased DNA binding activity of STAT3 | c-Fos, NFATc1, OSCAR, RANKL | Decreased TRAP-positive multinucleated cells | [90, 91] |
Mice BMMs | STAT3 | Niclosamide | Decreased STAT3 phosphorylation at Ser727 | c-Fos, NFATc1, TRAP, OSCAR, av/b3 integrin, CTSK | Decreased TRAP-positive multinucleated cells | [95] |
Mice BMMs | JAK3/STAT3 | WHI-131 | Increased STAT3 phosphorylation at Ser727 | c-Fos, NFATc1 | Decreased TRAP-positive multinucleated cells | [98] |
Mice BMMs | STAT3 | LIF | Increased STAT3 phosphorylation | CTSK, NFATc1, TRAP, Atp6a3, c-Fos | Increased TRAP-positive multinucleated cells | [108] |